Semaglutide is also available to qualifying individuals under the brand name Wegovy
(37632497) The approach to severe hypoglycemia in a critically ill patient is to obtain IV access immediately (e.g., with an intraosseous line or intravenous line)
They are not intended for human or veterinary use, ingestion, injection, infusion, inhalation or topical application, and are not intended to diagnose, treat, cure, mitigate or prevent any disease
They provide real-world perspectives on tolerability, subjective effects, and practical considerations
10.7554/eLife.6892910.12688/wellcomeopenres.15010.1 60 OdiaY.KreislT